Acute and chronic MRI changes in the spine and spinal cord after surgical stem cell grafting in patients with definite amyotrophic lateral sclerosis: Post-infusion injuries are unrelated with clinical impairment

Magnetic Resonance Imaging

Volumn 31, Issue 8, 2013, Pages 1298-1308

  García Santos, José M ^a   Blanquer, Miguel ^b   Torres del Río, Silvia ^a   Iniesta, Francisca ^b   Espuch, Joaquín Gomez ^a,b   Pérez Espejo, Miguel Ángel ^b   Martínez, Salvador ^c   Moraleda, José M ^b  

^a HOSPITAL MORALES MESEGUER   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Magnetic resonance imaging; Spinal cord; Stem cells; Surgery

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC MYELOMALACIA; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; SPINAL CORD DISEASE; SPINAL CORD FUNCTION; SPINAL CORD HEMORRHAGE; SPINAL CORD LESION; SPINE DISEASE; TREATMENT RESPONSE;

AMYOTROPHIC LATERAL SCLEROSIS; MAGNETIC RESONANCE IMAGING; SPINAL CORD; STEM CELLS; SURGERY;

ACUTE DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CHRONIC DISEASE; COMORBIDITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPAIN; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84883740326     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2013.05.006     Document Type: Article

References (33)

1. Clinical Trials. ALS Therapy Development Institute. Updated, February 2012, accessed February 27th, 2012. http://www.als.net/ALS-Research/ALS-Clinical-Trials/.
2. Aggarwal S., Cudkowicz M. ALS drug development: reflections from the past and a way forward. Neurotherapeutics 2008, 5:516-527.
3. Eisen A. Amyotrophic lateral sclerosis: a 40-year personal perspective. J Clin Neurosci 2009, 16:505-512.
4. Bonilla S., Alarcón P., Villaverde R., Aparicio P., Silva A., Martínez S. Haematopoietic progenitor cells from adult bone marrow differentiate into cells that express oligodendroglial antigens in the neonatal mouse brain. Eur J Neurosci 2002, 15:575-582.
5. Bonilla S., Silva A., Valdés L., Geijo E., García-Verdugo J.M., Martínez S. Functional neural stem cells derived from adult bone marrow. Neuroscience 2005, 133:85-95.
6. Moraleda J.M., Blanquer M., Bleda P., Iniesta P., Ruiz F., Bonilla S., et al. Adult stem cell therapy: dream or reality?. Transpl Immunol 2006, 17:74-77.
7. Cabanes C., Bonilla S., Tabares L., Martinez S. Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration. Neurobiol Dis 2007, 26:408-418.
8. Vercelli A., Mereuta O.M., Garbossa D., Muraca G., Mareschi K., Rustichelli D., et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008, 31:395-405.
9. Mazzini L., Fagioli F., Boccaletti R., Mareschi K., Oliveri G., Olivieri C., et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:158-161.
10. Silani V., Cova L., Corbo M., Ciammola A., Polli E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004, 364:200-202.
11. Badayan I., Cudkowicz M.E. Is it too soon for mesenchymal stem cell trials in people with ALS?. Amyotroph Lateral Scler 2008, 9:321-322.
12. Slavin S., Kurkalli B.G., Karussis D. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders. Clin Neurol Neurosurg 2008, 110:943-946.
13. Suzuki M., Svendsen C.N. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci 2008, 31:192-198.
14. Lindvall O., Kokaia Z. Stem cells in human neurodegenerative disorders - time for clinical translation?. J Clin Invest 2010, 120:29-40.
15. Rice C.M., Scolding N.J. Autologous bone marrow stem cells - properties and advantages. J Neurol Sci 2008, 265:59-62.
16. Mazzini L., Vercelli A., Mareschi K., Ferrero I., Testa L., Fagioli F. Mesenchymal stem cells for ALS patients. Amyotroph Lateral Scler 2009, 10:123-124.
17. Mazzini L., Mareschi K., Ferrero I., Vassallo E., Oliveri G., Nasuelli N., et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 2008, 265:78-83.
18. Deda H., Inci M.C., Kürekçi A.E., Sav A., Kayihan K., Ozgün E., et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009, 11:18-25.
19. Mazzini L., Ferrero I., Luparello V., Rustichelli D., Gunetti M., Mareschi K., et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol 2010, 223:229-237.
20. Martínez HR, Molina-Lopez JF, Alez-Garza MT, Moreno-Cuevas JE, Caro-Osorio E, Gil-Valadez A, Gutierrez-Jimenez E, Zazueta-Fierro OE, Meza JA, Couret-Alcaraz P, Hernandez-Torre M. Stem cell transplantation in amyotrophic lateral sclerosis patients. Methodological approach, safety, and feasibility. Cell Transplant 2012 Feb 13. [Epub ahead of print].
21. Blanquer M., Moraleda J.M., Iniesta F., Gómez-Espuch J., Meca-Lallana J., Villaverde R., et al. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study. Stem Cells 2012, 30:1277-1285.
22. Blanquer M., Pérez-Espejo M.A., Martínez-Lage J.F., Iniesta F., Martinez S., Moraleda J.M. A surgical technique of spinal cord cell transplantation in amyotrophic lateral sclerosis. J Neurosci Methods 2010, 191:255-257.
23. Féron F., Perry C., Cochrane J., Licina P., Nowitzke A., Urquhart S., et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 2005, 128(pt 12):2951-2960.
24. Mackay-Sim A., Féron F., Cochrane J., Bassingthwaighte L., Bayliss C., Davies W., et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008, 131(pt 9):2376-2386.
25. Mazzini L., Mareschi K., Ferrero I., Miglioretti M., Stecco A., Servo S., et al. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy 2012, 14:56-60.
26. Brooks B.R., Miller R.G., Swash M. Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299.
27. Common Terminology Criteria for Adverse Events v4.0 (CTCAE). Publish Date: May 28, 2009. Acceded May 18th, 2012. http://www.acrin.org/Portals/0/Administration/Regulatory/CTCAE_4.02_2009-09-15_QuickReference_5x7.pdf.
28. Appel S.H., Engelhardt J.I., Henkel J.S., Siklos L., Beers D.R., Yen A.A., et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008, 71:1326-1334.
29. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J.M., Kassis I., et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010, 67:1187-1194.
30. Glass J.D., Boulis N.M., Johe K., Rutkove S.B., Federici T., Polak M., et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells 2012, 30:1144-1151.
31. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 2008, 107:1-19.
32. Buss A., Pech K., Kakulas B.A., Martin D., Schoenen J., Noth J., et al. Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury. Brain 2007, 130(Pt 4):940-953.
33. Matos Rojas I.A., Bertholdo D., Castillo M. Stem cells: implications in the development of brain tumors. Radiologia 2012, 54:221-230.